Autonomix Medical, Inc. Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

Rhea-AI Summary

Autonomix Medical (NASDAQ: AMIX), a medical device company specializing in nervous system disease diagnosis and treatment technologies, announced its participation in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference.

During the conference, CEO Brad Hauser shared insights about his career journey, his commitment to Autonomix, and his enthusiasm for the company's innovative technology. The presentation is now available for viewing on both the Virtual Investor website and the Events page in the Investors section of autonomix.com.

– Video webcast now available on-demand 

THE WOODLANDS, TX, July 22, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that Brad Hauser, Chief Executive Officer of Autonomix, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.

For the event, Mr. Hauser dove deeper into his dedication to the Company, how he got to where he is today, and provided insight into why he is passionate about the Company’s innovative technology.

The on-demand video webcast is now available on the Virtual Investor website as well as the Events page under the Investors section of the Company’s website (autonomix.com).

About Autonomix Medical, Inc.

Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.

We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.

For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.

Investor and Media Contact
JTC Team, LLC
Jenene Thomas
908.824.0775
autonomix@jtcir.com

FAQ

When did Autonomix Medical (AMIX) participate in the Virtual Investor Summer Spotlight Conference?

Autonomix Medical participated in the Virtual Investor 'What's Your Story' Summer Spotlight Conference, with the on-demand video webcast becoming available on July 22, 2025.

Who presented at the Autonomix Medical (AMIX) Virtual Investor Conference?

Brad Hauser, Chief Executive Officer of Autonomix Medical, presented at the conference, sharing his career journey and vision for the company.

Where can investors watch the Autonomix Medical (AMIX) Virtual Investor Conference presentation?

The presentation is available on-demand on the Virtual Investor website and in the Events page under the Investors section of autonomix.com.

What is Autonomix Medical's (AMIX) business focus?

Autonomix Medical is a medical device company focused on developing innovative technologies for diagnosing and treating diseases involving the nervous system.